Recombinant Human GADD45B (N-6His)

Description

EnkiLife provides the Recombinant Human GADD45B (N-6His) protein,aslo know as Growth Arrest and DNA Damage-Inducible Protein GADD45 Beta,Myeloid Differentiation Primary Response Protein MyD118,Negative Growth Regulatory Protein MyD118,GADD45B,MYD118, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Growth Arrest and DNA Damage-Inducible Protein GADD45 beta is produced by our E.coli expression system and the target gene encoding Met1-Arg160 is expressed with a 6His tag at the N-terminus.Accession:O75293. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:20 KDa. Background:Growth Arrest and DNA Damage-Inducible Protein GADD45 β (GADD45B) is a member of the GADD45 family. GADD45B has been shown to interact with MAP3K4, ASK1, MAP2K7, and GADD45GIP1. GADD45B is involved in the regulation of growth and apoptosis. GADD45B reacts to environmental stresses by mediating activation of stress-responsive MTK1/MEKK4 kinase, which is an upstream activator of both p38 and JNK MAPKs. In addition, GADD45B participates in the down-regulation of hepatocellular carcinoma (HCC). It may serve as a possible therapeutic target.